Abstract:Background and objective 177 Lu-labeled prostate-specific membrane antigen (PSMA) radiopharmaceutical therapy (RPT) represents a pivotal advancement in addressing prostate cancer. However, existing therapies, while promising, remain incompletely understood and optimized. Computational models offer potential insights into RPTs, aiding in clinical drug delivery enhancement. In this study, we investigate the impact of various physiological parameters on the delivery of 177 Lu-PSMA-617 RPT using the convection-diffusion-reaction (CDR) model. Methods Our investigation encompasses tumor geometry and surrounding tissue, characterized by well-defined boundaries and initial conditions. Utilizing the finite element method, we solve governing equations across a range of parameters: dissociation constant K D (1, 0.1, 0.01 [nM]), internalization rate (0.01–0.0001 [min −1 ]), diverse tumor shapes, and variable necrotic zone sizes. This model can provide an accurate analysis of radiopharmaceutical delivery from the injection site to the tumor cell, including drug transport in the vascular, interstitial, and intracellular spaces, and considering important parameters (e.g., drug extravasation from microvessels or to lymphatic vessels, the extracellular matrix, receptors, and intracellular space). Results Our findings reveal significant enhancements in tumor-absorbed doses as K D decreases. This outcome can be attributed to the higher affinity of radiopharmaceuticals for PSMA receptors as K D diminishes, facilitating a more efficient binding and retention of the therapeutic agent within the tumor microenvironment. Additionally, tumor-absorbed doses for K D ∼ 1 [nM] show an upward trend with higher internalization rates. This observation can be rationalized by considering that a greater internalization rate would result in a higher proportion of radiopharmaceuticals being taken up by tumor cells after binding to receptors on the cell surface. Notably, tumor shape and necrotic zone size exhibit limited influence on tumor absorbed dose. Conclusions The present study employs the CDR model to explore the role of physiological parameters in shaping 177 Lu-PSMA-617 RPT delivery. These findings provide insights for improving prostate cancer therapy by understanding radiopharmaceutical transport dynamics. This computational approach contributes to advancing our understanding of radiopharmaceutical delivery mechanisms and has implications for enhancing treatment efficacy.

Modeling of Proton Interaction with Organic Polymers: Implications for Cancer Therapy and Beyond

Efficient computational modeling of electronic stopping power of organic polymers for proton therapy optimization

Efficient Proton Transport Modelling for Proton Beam Therapy and Biological Quantification

Electron Nuclear Dynamics Simulations of Proton Cancer Therapy Reactions: Water Radiolysis and Proton- and Electron-Induced DNA Damage in Computational Prototypes

Aspects of the physical principles of the proton therapy with inclusion of nuclear interactions

Enhancing Tissue Equivalence in 7Li Heavy Ion Therapy with MC Algorithm Optimized Polymer-Based Bioinks

Enabling Clinical Use of Linear Energy Transfer in Proton Therapy for Head and Neck Cancer -- A Review of Implications for Treatment Planning and Adverse Events Study

Modelling beam transport and biological effectiveness to develop treatment planning for ion beam radiotherapy

Study of gamma, neutron, and proton interaction parameters of some immunotherapy drugs using EpiXs, NGCal, and PSTAR software

Particle tracking, recognition and LET evaluation of out-of-field proton therapy delivered to a phantom with implants

Proton beams in cancer treatments: Clinical outcomes and dosimetric comparisons with photon therapy

Analysis of Bragg Curve Parameters and Lateral Straggle for Proton and Carbon Beams

Investigating the potential contribution of inter-track interactions within ultra-high dose-rate proton therapy

Single proton LET characterization with the Timepix detector and artificial intelligence for advanced proton therapy treatment planning

Proton radiographs using position-sensitive silicon detectors and high-resolution scintillators

Microdosimetric Modeling of Biological Effectiveness for Boron Neutron Capture Therapy Considering Intra- and Intercellular Heterogeneity in 10B Distribution

Radiotherapy Proton Interactions in Matter

TH‐E‐M100E‐05: Energy Deposition Contributions From Secondary Particles in Proton Therapy

Dosimetric characteristics of 3D-printed and epoxy-based materials for particle therapy phantoms

Spatiotemporal modeling of radiopharmaceutical transport in solid tumors: Application to 177 Lu-PSMA therapy of prostate cancer

Clustered DNA Damage Patterns after Proton Therapy Beam Irradiation Using Plasmid DNA